Bank of America Securities analyst Travis Steed has maintained their bullish stance on ISRG stock, giving a Buy rating on September 26.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Travis Steed has given his Buy rating due to a combination of factors including Intuitive Surgical’s strategic investments in new technology and potential future advancements in cardiac procedures. Although current robotic technology does not significantly enhance cardiac surgeries like mitral valve repairs or coronary artery bypass grafting, Steed anticipates that Intuitive Surgical’s ongoing development efforts could unlock new opportunities in these areas.
Furthermore, Intuitive Surgical is leveraging its core competencies in precision, guidance, and control robotics, along with digital and imaging capabilities, to address new disease states that lack effective solutions. This forward-looking approach, combined with the company’s strong market position and potential for technological breakthroughs, underpins Steed’s optimistic outlook and Buy rating for Intuitive Surgical’s stock.
In another report released on September 26, Bernstein also assigned a Buy rating to the stock with a $685.00 price target.